Autophagy is essential for flavopiridol‑induced cytotoxicity against MCF‑7 breast cancer cells

Wang,Shuo; Wang,Kai; Wang,Huaiquan; Han,Jiankui; Sun,Hukui

doi:10.3892/mmr.2017.7815

Autophagy is essential for flavopiridol‑induced cytotoxicity against MCF‑7 breast cancer cells

Authors:
- Shuo Wang
- Kai Wang
- Huaiquan Wang
- Jiankui Han
- Hukui Sun
View Affiliations

Affiliations: Nephrology Department, Central Hospital of Zibo, Zibo, Shandong 255036, P.R. China, Nuclear Medicine Department, Central Hospital of Zibo, Zibo, Shandong 255036, P.R. China, Nuclear Medicine Department, Qilu Hospital, Jinan, Shandong 250012, P.R. China
Published online on: October 17, 2017 https://doi.org/10.3892/mmr.2017.7815
Pages: 9715-9720

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Flavopiridol (FP) exerts antitumoral effects by triggering tumor cell cycle arrest and cytotoxicity in human breast cancer cell lines. The potent antitumor activity of FP is through its inhibition of cyclin‑dependent kinases; however, this may not be the only mechanism of action. The present study aimed to investigate whether FP is able to induce autophagy and to examine the effects of autophagy on cell death in FP‑treated MCF‑7 human breast cancer cells. MCF‑7 cells were treated with either FP alone or FP in combination with chloroquine (CQ). Expression levels of autophagy‑related protein LC3B‑II and p62/sequestosome 1 (SQSTM1) were used to monitor autophagic flux. MCF‑7 cells were transfected with autophagy‑related 5 (ATG5) small interfering (si)RNA to block autophagy. Cell viability and cell cycle status were determined. Following incubation with FP, MCF‑7 cells exhibited significantly higher autophagy compared with untreated control cells, and the level of autophagy is comparable with cells under rapamycin induction, which was verified by immunodetection of LC3B‑II and p62/SQSTM1 expression and inhibition by CQ. The addition of CQ treatment or ATG5‑siRNA transfection against autophagy components attenuated the cytotoxic effects of FP treatment of MCF‑7 cells. Furthermore, this autophagy inhibition did not impair the FP‑induced cell cycle arrest. These results revealed that autophagy may be involved in FP‑induced MCF‑7 cell death and autophagy inhibition enhanced the tumor cell pro‑survival ability. It is possibly that potential autophagy regulatory drugs may be used as a chemotherapy adjuvant.

View Figures

View References

1	Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and Harvie MN: Risk determination and prevention of breast cancer. Breast Cancer Res. 16:4462014. View Article : Google Scholar : PubMed/NCBI
2	Austreid E, Lonning PE and Eikesdal HP: The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy. Expert Opin Pharmacother. 15:681–700. 2014. View Article : Google Scholar : PubMed/NCBI
3	Asghar U, Witkiewicz AK, Turner NC and Knudsen ES: The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
4	DiPippo AJ, Patel NK and Barnett CM: Cyclin-dependent kinase inhibitors for the treatment of breast cancer: Past, Present, and Future. Pharmacotherapy. 36:652–667. 2016. View Article : Google Scholar : PubMed/NCBI
5	Senderowicz AM and Sausville EA: Preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst. 92:376–387. 2000. View Article : Google Scholar : PubMed/NCBI
6	Sedlacek HH: Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol. 38:139–170. 2001. View Article : Google Scholar : PubMed/NCBI
7	Ravishankar D, Rajora AK, Greco F and Osborn HM: Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol. 45:2821–2831. 2013. View Article : Google Scholar : PubMed/NCBI
8	Iyer SP, Mejia J, Rosato AE, Grant S and Rosato RR: Flavopiridol-mediated multiple modulatory effects synergistically increase sensitivity to TRAIL-induced cell death in human leukemia cells. Cancer Res. 73(8 Suppl): S29602013. View Article : Google Scholar
9	Ali S, El-Rayes BF, Aranha O, Sarkar FH and Philip PA: Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells. Breast Cancer Res Treat. 90:25–31. 2005. View Article : Google Scholar : PubMed/NCBI
10	Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG and Bhalla K: Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res. 63:93–99. 2003.PubMed/NCBI
11	Li Y, Bhuiyan M, Alhasan S, Senderowicz AM and Sarkar FH: Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. Clin Cancer Res. 6:223–229. 2000.PubMed/NCBI
12	Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science. 290:1717–1721. 2000. View Article : Google Scholar : PubMed/NCBI
13	Weiner LM and Lotze MT: Tumor-cell death, autophagy, and immunity. N Engl J Med. 366:1156–1158. 2012. View Article : Google Scholar : PubMed/NCBI
14	Mahoney E, Byrd JC and Johnson AJ: Autophagy and ER stress play an essential role in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Autophagy. 9:434–435. 2013. View Article : Google Scholar : PubMed/NCBI
15	Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, et al: Autophagy in malignant transformation and cancer progression. EMBO J. 34:856–880. 2015. View Article : Google Scholar : PubMed/NCBI
16	Rosenfeldt MT and Ryan KM: The multiple roles of autophagy in cancer. Carcinogenesis. 32:955–963. 2011. View Article : Google Scholar : PubMed/NCBI
17	Mahoney E, Lucas DM, Gupta SV, Wagner AJ, Herman SE, Smith LL, Yeh YY, Andritsos L, Jones JA, Flynn JM, et al: ER stress and autophagy: New discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood. 120:1262–1273. 2012. View Article : Google Scholar : PubMed/NCBI
18	Xie ZZ, Li MM, Deng PF, Wang S, Wang L, Lu XP, Hu LB, Chen Z, Jie HY, Wang YF, et al: Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem Biol Interact. 264:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
19	Singh A, Chagtoo M, Tiwari S, George N, Chakrabarti B, Khan S, Lakshmi S and Godbole MM: Inhibition of inositol 1,4,5-trisphosphate receptor induce breast cancer cell death through deregulated autophagy and cellular bioenergetics. J Cell Biochem. 118:2333–2346. 2017. View Article : Google Scholar : PubMed/NCBI
20	Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, Arai H, Tanaka K, Kominami E and Uchiyama Y: The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun. 382:419–423. 2009. View Article : Google Scholar : PubMed/NCBI
21	Shibata M, Yoshimura K, Tamura H, Ueno T, Nishimura T, Inoue T, Sasaki M, Koike M, Arai H, Kominami E and Uchiyama Y: LC3, a microtubule-associated protein1A/B light chain3, is involved in cytoplasmic lipid droplet formation. Biochem Biophys Res Commun. 393:274–279. 2010. View Article : Google Scholar : PubMed/NCBI
22	Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Arozena A Acevedo, Adachi H, Adams CM, Adams PD, Adeli K, et al: Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3rd edition). Autophagy. 12:1–222. 2016. View Article : Google Scholar : PubMed/NCBI
23	Ye H, Chen M, Cao F, Huang H, Zhan R and Zheng X: Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis. BMC Neurol. 16:1782016. View Article : Google Scholar : PubMed/NCBI
24	Shao X, Gao D, Wang Y, Jin F, Wu Q and Liu H: Application of metabolomics to investigate the antitumor mechanism of flavopiridol in MCF-7 breast cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci. 1025:40–47. 2016. View Article : Google Scholar : PubMed/NCBI
25	Filippi-Chiela EC, Villodre ES, Zamin LL and Lenz G: Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One. 6:e208492011. View Article : Google Scholar : PubMed/NCBI
26	Asghar U, Witkiewicz AK, Turner NC and Knudsen ES: The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
27	Carlson B, Lahusen T, Singh S, Loaiza-Perez A, Worland PJ, Pestell R, Albanese C, Sausville EA and Senderowicz AM: Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res. 59:4634–4641. 1999.PubMed/NCBI
28	Carlson B, Pearlstein R, Naik R, Sedlacek H, Sausville E and Worland P: Inhibition of CDK2, CDK4 and CDK7 by flavopiridol and structural analogs. Proc Am Assoc Cancer Res. 37:pp. 4241996;
29	Worland PJ, Kaur G, Stetler-Stevenson M, Sebers S, Sartor O and Sausville EA: Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells: Correlation with decreased H1 kinase activity. Biochem Pharmacol. 46:1831–1840. 1993. View Article : Google Scholar : PubMed/NCBI
30	Kim DE, Kim Y, Cho DH, Jeong SY, Kim SB, Suh N, Lee JS, Choi EK, Koh JY, Hwang JJ and Kim CS: Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of AMP-activated protein kinase. Mol Cells. 38:138–144. 2015. View Article : Google Scholar : PubMed/NCBI
31	Sun WL, Chen J, Wang YP and Zheng H: Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
32	Kimmelman AC: The dynamic nature of autophagy in cancer. Genes Dev. 25:1999–2010. 2011. View Article : Google Scholar : PubMed/NCBI
33	Akkoç Y, Berrak Ö, Arısan ED, Obakan PÇoker-Gürkan A and Palavan-Ünsal N: Inhiition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells. Biomed Pharmacother. 71:161–171. 2015. View Article : Google Scholar : PubMed/NCBI
34	Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 18:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI
35	Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B and Levine B: Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 72:8586–8596. 1998.PubMed/NCBI
36	Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
37	Yu J, Chen C, Xu T, Yan M, Xue B, Wang Y, Liu C, Zhong T, Wang Z, Meng X, et al: Pseudolaric acid B activates autophagy in MCF 7 human breast cancer cells to prevent cell death. Oncol Lett. 11:1731–1737. 2016.PubMed/NCBI